AI Science Tracker

CellOracle-guided pancreatic islet differentiation experiments reveal STAT1 and ZEB1 lineage roles

Washington University School of Medicine; University of Miami · 30 Apr 2026 · biology

Discovery

CellOracle-guided pancreatic islet differentiation experiments reveal STAT1 and ZEB1 lineage roles

A digital model built from 400,603 cells across 61 single-cell datasets used CellOracle gene-regulatory-network inference and in-silico transcription-factor perturbations to nominate regulators of stem-cell-derived human islet differentiation. CRISPRi experiments supported a previously unreported role for STAT1 in exocrine specification: transient STAT1 knockdown reduced exocrine markers, and JAK–STAT inhibition preserved beta-cell markers and improved glucose-stimulated insulin secretion. CRISPRi also supported a stage-dependent role for ZEB1, whose early knockdown impaired endocrine specification and later knockdown reduced off-target serotonergic cells while increasing beta-cell proportion. The date is the first preprint posting; this entry summarizes the later version reviewed in the research record, which reports the specific STAT1 and ZEB1 experiments.

Technology: CellOracle v0.12.0 within a digital model integrating single-cell transcriptomic and chromatin-accessibility data

Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Preprint
  • Test type: direct test
  • Tested: CRISPRi experiments supported a previously unreported role for STAT1 in exocrine specification: transient STAT1 knockdown reduced exocrine markers, and JAK–STAT inhibition preserved beta-cell markers and improved glucose-stimulated insulin secretion.
  • Still unknown: This is a bioRxiv preprint (first posted 30 April 2026; the source lists a later version on 17 September 2026), not peer-reviewed at this source date. It integrates existing datasets and reports laboratory validation in stem-cell-derived islet cultures; it does not establish human therapeutic benefit or mature clinical transplantation outcomes. Regulatory-model predictions remain context- and stage-dependent.
  • AI role: The integrated cell-state model inferred regulatory networks and performed in-silico transcription-factor knockout simulations to identify candidate lineage regulators and intervention windows. These model predictions guided subsequent CRISPRi and pharmacologic perturbations in stem-cell-derived islet differentiation cultures.

Evidence sources: https://www.biorxiv.org/content/10.64898/2026.04.27.721124v2.full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.